Cargando…
Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43
Immune checkpoint therapies (ICT) have achieved unprecedented efficacy in multiple cancer treatments, but are still limited by low clinical response rates. Identification of immunogenic cell death (ICD)‐inducing drugs that can induce tumor cell immunogenicity and reprogram the tumor microenvironment...
Autores principales: | Yin, Mingxiao, Dong, Jingwen, Sun, Cuicui, Liu, Xiaojia, Liu, Zhirui, Liu, Lu, Kuang, Zean, Zhang, Na, Xiao, Dian, Zhou, Xinbo, Deng, Hongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161045/ https://www.ncbi.nlm.nih.gov/pubmed/36876644 http://dx.doi.org/10.1002/advs.202206737 |
Ejemplares similares
-
Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR
por: Liu, Xiaojia, et al.
Publicado: (2021) -
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS
por: Yu, Chien-Hsiung, et al.
Publicado: (2020) -
cGAS-independent STING activation in response to DNA damage
por: Unterholzner, Leonie, et al.
Publicado: (2019) -
cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020) -
Manganese(ii) complexes stimulate antitumor immunity via aggravating DNA damage and activating the cGAS-STING pathway
por: Cai, Linxiang, et al.
Publicado: (2023)